SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-037888
Filing Date
2018-06-14
Accepted
2018-06-14 19:19:01
Documents
2
Period of Report
2018-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4032
2 POA DOCUMENT poa.txt EX-24.3_796650 4000
  Complete submission text file 0001209191-18-037888.txt   9353
Mailing Address 3290 WEST BAYSHORE RD PALO ALTO CA 94303
Business Address
OCLASSEN GLENN A (Reporting) CIK: 0001210529 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38529 | Film No.: 18900443

Mailing Address 200 GARRETT STREET CHARLOTTESVILLE VA 22902
Business Address 200 GARRETT STREET CHARLOTTESVILLE VA 22902 434-980-8100
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations